Cancer biology & therapy

Cancer Biol Ther · ISSN (e) 1555-8576 · 13 papers in corpus
2025
doi:10.1080/15384047.2025.2582349 ·PMID:41369154

BackgroundAberrant N6-methyladenosine (m6A) modification is linked to cancer development and progression. However, the role of YTH N6-methyladenosine RNA binding protein F2 (YTHDF2), an m6A 'reader protein', in nasopharyngeal carcinoma (NPC…

2023
doi:10.1080/15384047.2023.2249174 ·PMID:37639643

Infection with high-risk human papillomavirus (HPV), for example, with types 16 and 18, is closely associated with cervical cancer development, which continues to threaten women's health globally. Although HPV oncogenes have been recognized…

2021
doi:10.1080/15384047.2021.1877864 ·PMID:33618612

Oral squamous cell carcinoma (OSCC) is one of the most common malignancies worldwide. Emerging evidence has suggested that long noncoding RNAs (lncRNAs) play vital roles in various biological processes of cancers, such as cell proliferation…

review 2020
doi:10.1080/15384047.2020.1736483 ·PMID:32174282

Many types of cancers, including endometrial cancer, were found to have cyclooxygenase-2 (COX-2) overexpression. Because this enzyme belongs to the group of pro-inflammatory enzymes, so-called NSAIDs (non-steroidal anti-inflammatory drugs) …

article 2019
doi:10.1080/15384047.2019.1595278 ·PMID:30913953

: The EAOC patients were often diagnosed at a younger age, an earlier stage, and related to nulliparity and infertility. Patients with EAOC had a better prognosis than non-EAOC, early stage rather than association with endometriosis may be …

2019
doi:10.1080/15384047.2018.1523853 ·PMID:30359167

ObjectiveUterine carcinosarcomas (UCSs) are aggressive rare tumors recognized as malignancies composed of metaplastic transformation of epithelial elements. Nay no comprehensive molecular classification has been applied to UCS to guide targ…

2017
doi:10.1080/15384047.2017.1281495 ·PMID:28118070

BackgroundUterine malformation is a rare deformity in woman, and only a few cases concerning endometrial cancer arising in patients with congenital uterine anomalies have been reported. Herein, we present 3 cases of endometrial cancer with …

article 2017
doi:10.1080/15384047.2017.1281496 ·PMID:28112582

The purpose of this study was to test the effect of MK2206, an allosteric inhibitor of AKT, on the growth and invasion of patient-derived xenografts (PDX) of endometrial cancer. Three PDX lines, USC1 (uterine serous), EEC2 (endometrioid gra…

2016
doi:10.1080/15384047.2016.1190486 ·PMID:27195611

Vascular Endothelial Growth Factor (VEGF) mediates angiogenesis, which is crucial for tumor development and progression. The present study aimed to evaluate the impact of VEGFA gene polymorphisms rs699947, rs833061, rs1570360, rs2010963 and…

2015
doi:10.1080/15384047.2015.1056411 ·PMID:26147747

Epigenetic changes play significant roles in cancer development. UHRF1, an epigenetic regulator, has been shown to be overexpressed and to coordinate tumor suppressor gene (TSG) silencing in several cancers. In a previous study, we found th…

2014
doi:10.4161/cbt.26708 ·PMID:24309512

Sorafenib (Nexavar) is a multi-kinase inhibitor that was developed as an inhibitor of RAF-1, in the ERK1/2 pathway, but which was subsequently shown to inhibit class III tyrosine kinase receptors. (1) More recently regorafenib (Stivarga) ha…

2014
doi:10.4161/cbt.28411 ·PMID:24618703

ARID1A has emerged as a tumor suppressor gene, which is mutated in a broad spectrum of cancers, especially in those arising from ectopic or eutopic endometrium. As a subunit of SWI/SNF chromatin remodeler, ARID1A facilitates target-specific…

article 2012
doi:10.4161/cbt.20084 ·PMID:22555803

Inflammatory cells play important roles in progression of solid neoplasms including ovarian cancers. Tumor-associated macrophages (TAMs) contribute to angiogenesis and immune suppression by modulating microenvironment. Ovarian cancer develo…